Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic

OBJECTIVE: The approval of immunotherapy (I-O) for the treatment of late-stage non-small cell lung cancer (NSCLC) opened new perspectives in improving survival outcomes. However, survival data have not yet been provided from the period of the Covid-19 pandemic. The aims of our study were to assess a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiss, Zoltán, Gálffy, Gabriella, Müller, Veronika, Moldvay, Judit, Sárosi, Veronika, Pápai-Székely, Zsolt, Csada, Edit, Kerpel-Fronius, Anna, Király, Zsolt, Szász, Zoltán, Hódi, Gábor, Polányi, Zoltán, Kovács, Krisztina, Karamousouli, Eugenia, Knollmajer, Kata, Szabó, Tamás G., Berta, Andrea, Vokó, Zoltán, Rokszin, György, Abonyi-Tóth, Zsolt, Barcza, Zsófia, Tamási, Lilla, Bogos, Krisztina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584310/
https://www.ncbi.nlm.nih.gov/pubmed/37860193
http://dx.doi.org/10.3389/fonc.2023.1207295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584310/
https://www.ncbi.nlm.nih.gov/pubmed/37860193
http://dx.doi.org/10.3389/fonc.2023.1207295

Ejemplares similares